GSK Investigational Site

Camperdown, New South Wales 2050

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Camperdown,
Click here to add this to my saved trials
Cholestasis Clinical Trial
Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Camperdown,
Click here to add this to my saved trials